Advertisement · 728 × 90
#
Hashtag

#ESCMiD

Advertisement · 728 × 90

The talk highlighted how economic evaluation can inform policy decisions and prioritise impactful AMR prevention strategies.

The session was co-hosted by #ESCMID, the Global Leaders Group on #AMR, #CARB-X, #LifeArc, #NovoNordiskFoundation, and #GatesFoundation.

#HealthEconomics #ESCMIDGlobal2026

0 0 0 0
Post image

Great day yesterday at #ESCMID! @ilanareinhold.bsky.social presented a poster on Antifungal Therapy & Treatment Response in Chronic Disseminated Candidiasis (111 cases). Inspiring discussions, strong international collaboration & great to reconnect globally. #Candida #InfectiousDiseases

2 1 0 0

Irony is dead.

@escmid.bsky.social screening Don't Look Up 😵‍💫

#ESCMID #ESCMID2026 #ESCMIDGlobal2026
#MedSky #EpiSky @ipaccanada.bsky.social @ukhsa.bsky.social

8 1 1 0
Post image Post image Post image

Still at #ESCMIDglobal2026?
While our official #MeetECDCExperts sessions are over, there is always somebody interesting to chat with at the #ECDC booth!

So pass by, let's talk SCIENCE!
Hall B2, booth 81, next to the flags.

And thank you to everyone that paid us a visit so far! <3
#ESCMID

6 2 0 0
Post image

Proud of our team at #ESCMID in Munich! Two great posters today: Luise Hänsel on the 2025 EQUAL Pneumocystis Score & @salmantongarcia.bsky.social Salmanton-García on capacity for invasive fungal diseases in LATAM/Caribbean. Strong results, true team spirit! #Mycology #ID

4 1 1 0
Research in context panel for a paper published in The Lancet, entitled "Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial". Copyright: 2026 Elsevier Ltd. All rights reserved.

Research in context panel for a paper published in The Lancet, entitled "Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial". Copyright: 2026 Elsevier Ltd. All rights reserved.

A new study, presented at @escmid.bsky.social, found that Nitrofurantoin was the most effective treatment and single-dose fosfomycin the least effective treatment for uncomplicated urinary tract infections.

Explore the research 👉 spkl.io/63320A4Yui #ESCMIDGlobal2026 #ESCMID

15 9 1 0
Post image Post image

Day 2 #ESCMIDGlobal2026 with Ameca The Robot built by Engineered Arts.

I had a conversation about @escmid.bsky.social
study groups and all sessions.

Holy moly. This isn’t the future of healthcare & tech, it’s already here. 🤖

Come meet Ameca 🙂
#ESCMID #AIinHealthcare #FutureNow #ESGAID

0 0 0 0
Post image Post image

Thrilled and proud of Marco Delaye at #ESCMID in Munich. Ralstonia tomassi outbreak in CLABSI @INCan

0 0 0 0
Post image

Day 2 at #ESCMID - great to see first contributions from Cologne! 🙌
Starting with an oral session on viral infections in immunocompromised hosts, chaired by @salmantongarcia.bsky.social from our team.
Amazing Bavarian-style atmosphere, sunshine & beer garden vibes ☀️🍻
#InfectiousDiseases #Science

4 1 0 0
Post image

At #ESCMIDglobal2026 this weekend?

Meet the #ECDC experts at the venue!
Check the schedule below, pass by and chat with us on the topics that you are interested most!

Hall B2, booth 81, next to the flags.
#MeetECDCExperts #MeetYourECDCExpert #PublicHealth #ESCMID

4 1 0 0
Post image

ESCMID Global 2026 is underway in Munich.

Our team is on site, bringing months of planning to life and supporting a key global platform for scientific exchange.

Proud to be part of it.

#Congrex #ESCMID #OnSite #ScientificExchange

0 0 0 0
Post image

At #ESCMID this afternoon and looking for something genuinely worthwhile? Join our two-hour educational session: Clinical Challenges in Tropical Medicine, lessons for global health.

🕐 13:30–15:30📍 Session Hall ICM 5

We have an outstanding group of speakers from across the globe
#ESCMIDGlobal2026

4 2 0 0
Post image Post image Post image

Ineos Oxford Institute for antimicrobial research (IOI) at ESCMID Global 2026: Munich, Germany

Researchers from the IOI are presenting over 45 posters and talks at this year's ESCMID conference.

👉Explore the schedule of IOI presentations: https://ow.ly/i5JV50YIiLr

#ESCMID

2 0 0 0
Screenshot of an app welcome screen

Screenshot of an app welcome screen

Well, this is depressing. Fired up #ESCMID app for the first time and it’s literally a title screen with no menu nor anything to tap. I’m running the latest iOS, so no idea! (Last year’s still working.) Anyone else having issues? Maybe it’s just overwhelmed by too many users?
😢 @escmid.bsky.social

0 1 2 0

Heading to @escmid.bsky.social Global in Munich this weekend?

Stop by the @lshtm.bsky.social stand to say hello - we’d love to share opportunities for further study and update you on upcoming alumni activities. 👋

Hope to see you there!

#LSHTM #ESCMID

1 0 0 0
Post image

Hear Martin McHugh at #ESCMID discuss how shifting from a targeted to holistic sequencing approach is changing how pathogens and AMR are understood — supporting stronger surveillance and more informed responses in clinical and public health settings. https://bit.ly/4sVgJWa

2 0 1 0
Post image

Don’t Jason Hendry at #ESCMID to uncover how they are surveying malaria in real-time. Using portable Oxford Nanopore technology in the field, this work is bringing actionable insights closer to communities and public health teams who need it most. https://bit.ly/4uQNpSw

4 0 0 0

Looking forward to #ESCMID next week. Happy to chat all things real world evidence there.

0 0 0 0
Post image

In her #ESCMID talk, Sofia Brunet will share how routine bacterial identification in Sweden is becoming faster and more confident. Discover how Oxford Nanopore 16S sequencing is supporting this with rapid, accurate, actionable microbial insights. https://bit.ly/41oHO8g

2 0 1 0
Post image Post image

Dear ESGUTIs, we would LOVE your support on two ongoing surveys within ESGUTI! Please vote and spread the word, we need your expertise 🤩🫶 Thank you, you are the BEST! #UTISky #ESGUTI #ESCMID #IDSky

3 3 0 0
Post image

When outbreaks spread fast, time to answer matters as much as the answer itself.
Join us at #ESCMID to hear how researchers are making faster, more informed, and more impactful decisions using Oxford Nanopore sequencing for rapid, rich microbial insights. https://bit.ly/3NBP4uo

1 0 1 0
Post image

📍Visit us at booth #F21 at #ESCMID Global 2026 in Munich!

Innovation in ID requires strong partnerships.

🔬At Ecraid we're committed to building & growing collaborations across Europe to strengthen clinical research & tackle AMR.

Meet our team & explore how we can work together: bit.ly/474r0qy

1 0 1 0
Post image

Next month, we will present multiple posters and oral presentations during the @ESCMIDGlobal, but 2 are among the top 2% of highest rated submissions.
We see you in Munich! #surveillance #collaboration #RIVM #SSI #genomics #plasmids #outbreak #ESCMID #ESGMAP #CPEsurveillanceStudyGroup #ECDC

0 0 0 0
Post image

Don’t forget to register for our first webinar next Monday (9th March) at 8pm CET!!! 🎉🥳🎊 we can’t wait to see you there! @bill-lab.bsky.social @immunobladder.bsky.social

#UTISky #IDSky #ESGUTI #ESCMID

2 2 0 1
Post image

Register now for our first webinar of 2026!!! 🎉🥳🎊

#UTISky #IDSky #ESGUTI #ESCMID

5 3 0 1

📢 ESGEM Members attending #ESCMIDGlobal2026!

Join us for our annual Business Meeting to discuss our activities, network, and shape the future of our study group.

🗓️ Date: Saturday, 18.04.2026 ⏰ Time: 11:00 - 12:00 📍 Room: ICM 2

See you there! 👋

#ESGEM #ClinicalMicrobiology #Epidemiology #ESCMID

0 1 0 0
Confocal micrograph of a purple urothelium covered with bacteria - see https://www.biorxiv.org/content/10.1101/2025.11.12.688052v1

Confocal micrograph of a purple urothelium covered with bacteria - see https://www.biorxiv.org/content/10.1101/2025.11.12.688052v1

Pleased to reveal that our team has been selected for 2 oral presentations at #ESCMID
@escmid.bsky.social Global in Munich! Both lines of research spearheaded by the fabulous @microberamon.bsky.social. #UTI isn’t just a serious healthcare problem - the science is an intriguing puzzle! #IDSky #UTISky

7 3 1 0

We are pleased to share our fourth and final newsletter of 2025 (tinyurl.com/bdhf7uhm). We are bringing you summaries of the year, activities to look forward to, and we are introducing a Slack workspace to facilitate idea sharing and collaboration. #ESCMID #ESGMAP #plasmids #newsletter #AMR #webinar

0 0 0 0

Excellent idea to attend both #ESCMID Global @escmid.bsky.social and the #Shigella meeting! 🔬 🧫 🦠

2 0 0 0

🧬 How do we evaluate structural variations in plasmids?

Find out in the final ESGMAP webinar in 2025.

💥Dr. Daria Frolova presents "Studying plasmid relatedness and evolution through structural variation"
📅15 December, 12:00 CET
🔗Registration required (link in comments)

#ESCMID #ESGMAP #plasmids

3 2 1 1